淋巴瘤
CD8型
背景(考古学)
T细胞受体
人口
T细胞
滤泡性淋巴瘤
淋巴结
生物
嵌合抗原受体
免疫学
基因重排
癌症研究
免疫系统
医学
遗传学
基因
环境卫生
古生物学
作者
Katie Maurer,Jackson A. Weir,Adi Nagler,Nicholas J. Haradhvala,Hariharan Bharadwaj,Jacob Shapiro,Somkene D. Alakwe,Vipin Kumar,Brianna F Waller,Mikaela M. McDonough,Jamie Dela Cruz,Loida Luna,Emma S. Lin,Linsey Gong,Qiyu Gong,Mehdi Borji,Phillip D. Michaels,Jacob P. Laubach,Geraldine Pinkus,Gad A. Getz
标识
DOI:10.1038/s41467-025-62709-7
摘要
Reports of secondary malignancies after chimeric antigen receptor (CAR)-T and possible CAR-T derived malignant transformation necessitate caution. Here we describe a patient with diffuse large B-cell lymphoma who developed new lymphadenopathy 2.5 years after CAR-T in the context of COVID-19 infection with histopathologic features consistent with T-cell lymphoma (TCL). Deep molecular interrogation with genomic sequencing and single-cell spatial transcriptomics reveals a highly proliferative clonal T-cell population co-expressing CD4 and CD8 with biallelic TCR rearrangement and no evidence of the CAR construct. The expanded clonotype displayed T follicular helper (TFH) cell transcriptomic programs and occupies immune-excluded spatial niches within the lymph node, supportive of TFH-like neoplastic T cell behavior. Remarkably, the lymphadenopathy spontaneously resolved on interval imaging. Our data underscore the need for better understanding of post-CAR-T clonal T-cell lymphoproliferative disorders to avoid unnecessary treatment and higher specificity in diagnostic methods for TCL.
科研通智能强力驱动
Strongly Powered by AbleSci AI